Innovis Asset Management LLC Eye Point Pharmaceuticals, Inc. Transaction History
Innovis Asset Management LLC
- $260 Billion
- Q3 2023
A detailed history of Innovis Asset Management LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Innovis Asset Management LLC holds 19,031 shares of EYPT stock, worth $165,569. This represents 0.06% of its overall portfolio holdings.
Number of Shares
19,031
Previous 19,031
-0.0%
Holding current value
$165,569
Previous $166 Million
8.16%
% of portfolio
0.06%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding EYPT
# of Institutions
176Shares Held
53.9MCall Options Held
764KPut Options Held
1.57M-
Cormorant Asset Management, LP Boston, MA6.89MShares$60 Million8.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.76MShares$41.4 Million0.19% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.76MShares$32.7 Million3.33% of portfolio
-
Franklin Resources Inc San Mateo, CA3.39MShares$29.5 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$24.3 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $296M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...